High glucose treatment promotes extracellular matrix proteome remodeling in Muller glial cells.
PeerJ 9:e11316 (2021)
Background. The underlying pathomechanisms in diabetic retinopathy (DR) remain incompletely understood. The aim of this study was to add to the current knowledge about the particular role of retinal Muller glial cells (RMG) in the initial processes of DR.Methods. Applying a quantitative proteomic workflow, we investigated changes of primary porcine RMG under short term high glucose treatment as well as glycolysis inhibition treatment.Results. We revealed significant changes in RMG proteome primarily in proteins building the extracellular matrix (ECM) indicating fundamental remodeling processes of ECM as novel rapid response to high glucose treatment. Among others, Osteopontin (SPP1) as well as its interacting integrins were significantly downregulated and organotypic retinal explant culture confirmed the selective loss of SPP1 in RMG upon treatment. Since SPP1 in the retina has been described neuroprotective for photoreceptors and functions against experimentally induced cell swelling, it's rapid loss under diabetic conditions may point to a direct involvement of RMG to the early neurodegenerative processes driving DR. Data are available via ProteomeXchange with identifier PXDO15879.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Diabetic Retinopathy ; Secreted Phosphoprotein 1 (spp1) ; Osteopontin ; Neurodegeneration ; Organotypic Explant Cultures ; Translational Large Animal Model ; Pig; Data-independent Acquisition; Diabetic-retinopathy; Identification; Proteins; Survival; Cultures; Retina; Edema; Model
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
2167-8359
e-ISSN
2167-8359
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 9,
Issue: ,
Pages: ,
Article Number: e11316
Supplement: ,
Series
Publisher
PeerJ
Publishing Place
341-345 Old St, Third Flr, London, Ec1v 9ll, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505700-001
A-630700-001
Grants
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2021-06-23